Medical News

RSS

Bitplane announces launch of Imaris 8.2 with ImarisLineage at ASCB 2015

Bitplane, an Oxford Instruments Company and world leader in 2 to 4D image visualization, analysis and interpretation, has announced the launch of Imaris 8.2 at the American Society for Cell Biology Annual Meeting in San Diego on December 13, 2015.

21 Dec 2015

Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients

Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.

21 Dec 2015

Protective effects of high fitness against early death reduced in obese people, study finds

A new study, published today in the International Journal of Epidemiology, has dismissed the concept of 'fat but fit'. In contrast, the results from the new study suggest that the protective effects of high fitness against early death are reduced in obese people.

20 Dec 2015

Combination therapy can help overcome endocrine resistance in women with advanced breast cancer

Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.

20 Dec 2015

Endoscopic submucosal dissection appears to be effective treatment for patients with throat cancer

According to a study in the December issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, endoscopic submucosal dissection (ESD) appears to be a safe and effective minimally invasive treatment for patients with superficial pharyngeal (throat) cancer.

20 Dec 2015

USC-led study finds link between anxiety and dementia

People who experienced high anxiety any time in their lives had a 48 percent higher risk of developing dementia compared to those who had not, according to a new study led by USC researchers.

20 Dec 2015

New discovery may soon make prostate cancer cells easier to destroy

A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.

20 Dec 2015

New data shows opioid overdose deaths hit record levels in 2014

From 2000 to 2014 nearly half a million Americans died from drug overdoses. Opioid overdose deaths, including both opioid pain relievers and heroin, hit record levels in 2014, with an alarming 14 percent increase in just one year, according to new data published today in CDC's Morbidity and Mortality Weekly Report.

20 Dec 2015

Coffee may help improve athletic endurance

The caffeine in a morning cup of coffee could help improve athletic endurance, according to a new University of Georgia review study.

20 Dec 2015

New NYUCN study examines validity of symptoms for detecting breast cancer-related lymphedema

Many are aware that hair loss is a common side effect associated with chemotherapy. However, another albeit common late side effect of cancer treatment is the abnormal swelling of one or more limbs, known as lymphedema. Lymphedema is most commonly the result of an obstruction or disruption of the lymphatic system that occurs immediately after cancer treatment or 1-5, even 20 years after.

20 Dec 2015

Teens with moderate mental health problems vape e-cigarettes

Teenagers with moderate mental health problems who may not have considered smoking conventional cigarettes are turning to electronic cigarettes, a new USC study has found.

20 Dec 2015

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today emphasizes the continued availability of Daraprim and cautions healthcare providers of proposed alternatives to Daraprim.

20 Dec 2015

Variant signs worldwide exclusive license and development agreement with L&F Research

Variant Pharmaceuticals, Inc., an emerging pharmaceutical company focusing on rare diseases and other specialty conditions with limited or sub-optimal therapeutic options, announced today a worldwide exclusive license and development agreement with L&F Research LLC to advance development of Variant's lead product, VAR 200.

20 Dec 2015

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex Corporation today announced that it has received FDA clearance for its NxTAG Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumonia.

20 Dec 2015

GSI Group purchases SkyeTek assets for $2.6 million

GSI Group Inc., a global leader and supplier of laser, precision motion, and vision technologies to original equipment manufacturers ("OEM") in the medical and advanced industrial markets, today announced it has acquired the assets of SkyeTek, a Denver, Colorado-based provider of embedded and standalone RFID Solutions for medical OEM's for $2.6 million in cash, subject to customary working capital adjustments.

20 Dec 2015

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer.

20 Dec 2015

Medical News

Bitplane announces launch of Imaris 8.2 with ImarisLineage at ASCB 2015

Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients

Protective effects of high fitness against early death reduced in obese people, study finds

Combination therapy can help overcome endocrine resistance in women with advanced breast cancer

Endoscopic submucosal dissection appears to be effective treatment for patients with throat cancer

USC-led study finds link between anxiety and dementia

New discovery may soon make prostate cancer cells easier to destroy

New data shows opioid overdose deaths hit record levels in 2014

Coffee may help improve athletic endurance

New NYUCN study examines validity of symptoms for detecting breast cancer-related lymphedema

Teens with moderate mental health problems vape e-cigarettes

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Variant signs worldwide exclusive license and development agreement with L&F Research

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

GSI Group purchases SkyeTek assets for $2.6 million

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

FDA approves Fenix Continence Restoration System to treat fecal incontinence

Common mechanism may underlie epilepsy, suicidality

Poor outlook for ICH associated with novel oral anticoagulants

Pauses and reversals ‘not uncommon’ in ALS progression

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News